APX: An intelligent buy
APX’s long-term growth opportunity is supported by increasing Artificial Intelligence data requirements from its major customers. The company is profitable
COH: Listen up, opportunity knocks
An excellent opportunity to add to your existing position, in what is a world-leading hearing aid (Cochlear implants) developer, at very attractive...
TYR: An attractive Tech opportunity
We see the current pull back as an opportunity to gain exposure to a technology leader, with an established growing market, at very attractive levels...
IMP Monthly Report | August 2020
August was another strong month, as global markets continued their remarkable recovery from the March lows amidst ongoing optimism regarding reopening...
Taking five with Alex Martin
The interesting takeaway for me has been the shift from traditional market favourites, such as big banks, Telstra and oil stocks, to emerging companies...
Negative interest rates: Rewarding profligacy
Presently there are trillions of dollars of bonds throughout the world with negative interest rates. This is an unprecedented turn of events...
Pan Asia Metals IPO
Pan Asia Metals has hit the ASX IPO market, with Baker Young as Joint Lead Manager, to raise $6M...
6.25% yield: Childcare… too important to fail
Delivering reliable 6.25% yield in a low rate environment, Charter Hall Social Infrastructure is one of Australia’s largest childcare centre landlords...
Taking five with Michael Zollo
"My clients get an edge when it comes to dealing in micro cap and small cap ASX listed companies..."
Company update: Alexium International
Whilst many businesses have been adversely affected due to the COVID-19 lockdown, Alexium International, from all reports is returning to more normal...
Codan Limited – local hero
BUY - Codan Limited (ASX:CDA) has a pristine balance sheet with $85M in net cash and trades on respectable 21x 12 month earnings forecasts...
IMP Monthly Report | July 2020
The Australian share market finished 0.5% higher in July, however, momentum was lost as spiking COVID-19 cases began to weigh on confidence...
Helping kids reach new heights
IPO OPPORTUNITY - Baker Young recently completed the $1.5M pre-IPO for Nutritional Growth Solutions. NGS is now moving towards a considered IPO...
Family Zone: Lets kids be kids
Small cap, corporate deal BUY - Family Zone lets kids be kids and empowers parents to be parents.
Newcrest: As governments keep pumping cash, inflation might just pop
Newcrest Limited (NCM:ASX)) is Australia’s largest and one of the world’s most significant gold producers, with annual production slated to exceed 2 million
Aristocrat: Strength outweighs short-term issues for growth
Blue chip BUY - Aristocrat is a growth company rather than a strong dividend stock so we see capital growth as focus for this investment.
Corporate deals: Access to discounted share offers
A combination of access to discounted deals and advice from your broker can add to your portfolio’s bottom line. So how can you participate Corporate deals?
SUDA Pharmaceuticals rights issue
Currently trading at 3 cents, SUDA Pharmaceuticals is a small cap biopharmaceutical company which is focused on the reformulation of established drugs...